Viewing Study NCT02947620


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-01-07 @ 1:59 PM
Study NCT ID: NCT02947620
Status: COMPLETED
Last Update Posted: 2023-06-18
First Post: 2016-10-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)
Sponsor: Daewoong Pharmaceutical Co. LTD.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module